D

DelRicht Research | Grassroots Healthcare - Tulsa, OK

Research site

(Unclaimed)

Location

10100 S Mingo Rd, Tulsa, Oklahoma, United States of America

Site insights

Top conditions

Top treatments

Dihydroergotamine

X0002

STS101

LY3526318

LY3857210

LY3556050

Eptinezumab

ABP-671

Galcanezumab

EVO100

Parent organization

This site is a part of DelRicht Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-s...

Enrolling

Chronic Low-back Pain

Diabetic Neuropathic Pain

Drug: LY3016859 ISA

Drug: Placebo Oral

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the treatme...

Active, not recruiting

Acute Migraine

Drug: Placebo

Drug: Elismetrep (K-304) Dose level 3

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare th...

Active, not recruiting

Gout

Other: Placebo

Drug: Allopurinol

Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications (NAVIGATE)

The purpose of this study is to evaluate the effectiveness of CD388 in preventing symptomatic laboratory-confirmed influenza infections, as compared...

Active, not recruiting

Influenza

Combination Product: CD388 Injection

Combination Product: Placebo